ARCA biopharma competitorsClear all

Nightstar Therapeutics's top competitors include Bioblast Pharma.
Nightstar Therapeutics
Nightstar Therapeutics
Nightstar Therapeutics (formerly known as NightstaRx) is a clinical-stage gene therapy company focused on developing and commercializing novel one-time treatments for patients suffering from rare inherited retinal diseases.
Bioblast Pharma
Bioblast Pharma
Bioblast Pharma Ltd., a clinical-stage biotechnology company, develops therapies for patients with rare and ultra-rare genetic diseases.
Founding Date
Founding Date
2013
Founding Date
2012
Type
Type
Subsidiary
Type
Public
Tags
Locations
Locations
London, GB HQ
Lexington, US
Locations
Tel Aviv-Yafo, IL HQ
Employees
Employees
N/A
Employees
12

Financial

Net income
Net income
($12.2m) (FY, 2016)
Net income
($4.2m) (FY, 2018)

Funding

Total funding raised
Total funding raised
$ 99.6m
Total funding raised
$ 4.8m
For sources of this data, please see the company profile

View company profiles

Bioblast Pharma
HQ
Tel Aviv-Yafo, IL
Employees
12

Bioblast Pharma Ltd., a clinical-stage biotechnology company, develops therapies for patients with rare and ultra-rare genetic diseases.

View company